Search results
Author(s):
David Holmes Jr
Added:
3 years ago
Percutaneous coronary revascularization has revolutionized modern cardiovascular care. It has become one of the most well-studied and frequently performed procedures in modern medicine and is currently performed in more than 900,000 patients per year, exceeding the rate of coronary bypass surgery. It is used in an increasingly large number of patient subsets and used to treat an increasingly…
View more
Author(s):
Steve Attanasio
,
Raed Al Dallow
,
Sandeep Nathan
Added:
3 years ago
While acute coronary syndromes inclusive of ST-elevation myocardial infarction (STEMI) have been described in patients with polycythemia vera (PCV), optimal pharmacologic and interventional management strategies in the setting of drastically elevated platelet counts remain unclear.1 To our knowledge this is the first reported case of STEMI with massive thrombus burden in a patient with PCV…
View more
Author(s):
Charles L Campbell
,
Eric J Topol
,
Steven R Steinhubl
Added:
3 years ago
The complications of atherosclerotic disease comprise the primary cause of mortality in the world today. Acute complications such as sudden cardiac death, myocardial infarction and stroke are typically due to the formation of a intra-arterial thrombus at the site of a rupture or erosion of an atherosclerotic lesion, with platelet activation and aggregation central to thrombus formation. Aspirin,…
View more
ACS in the Elderly
Author(s):
Mansi Oberoi
,
Nitesh Ainani
,
J Dawn Abbott
,
et al
Added:
1 year ago
Article
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
7 months ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the first day of ESC Congress 2023.
Trials covered in detail include:
New ESC Guidelines for 2023 - 00:24 - 10:03
STEP-HFpEF - 10:04 - 12:03
COP-AF - 12:04 - 13:11
Recorded on-site at ESC Congress 2023, Amsterdam.
Editors: Mirjam Boros and Jordan…
View more
Author(s):
Michael Megaly
,
Marwan Saad
,
Emmanouil S Brilakis
Added:
3 years ago
Percutaneous coronary intervention (PCI) of small-vessel coronary artery disease (SVD) is challenging because of difficulties with equipment delivery and high restenosis rates. Drug-coated balloons (DCBs) are an attractive emerging PCI option for patients with SVD.
Small-vessel coronary artery disease
SVD was defined in the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small…
View more
Author(s):
Albert Alahmar
,
Anthony H Gershlick
Added:
3 years ago
Drug-eluting stents (DES) have revolutionized the field of interventional cardiology. The US Food and Drug Administration (FDA) is expecting that the total number of DES implanted in 2010 will surpass 5 million worldwide. Although initial results seemed promising, longer-term follow-up in a wider range of patients revealed some concerns. Enhanced platelet aggregation, delayed neointimal growth, a…
View more
Author(s):
Antonio Gutierrez
,
Sunil V Rao
Added:
3 years ago
Current evidence-based therapies for ischemic heart disease include antithrombotic and antiplatelet medications that reduce the risk for ischemic outcomes such as myocardial infarction and stroke.1 Given their mechanism of action, bleeding is a risk with these agents, especially when combined with invasive procedures.2 In addition to overt bleeding, clinical trials of antithrombotic strategies…
View more
Author(s):
Atsushi Sakamoto
,
Anne Cornelissen
,
Yu Sato
,
et al
Added:
2 years ago
Author(s):
Sara C Martinez
,
Sharonne N Hayes
Added:
3 years ago
Pregnancy is a physiologic challenge, with significant hormonal, metabolic, and hemodynamic changes. Cardiac output is objectively increased by the fifth week after the last menstrual period and continues to grow by approximately 45 % by 24 weeks in the normal, singleton pregnancy. This is facilitated by elevations in heart rate and stroke volume and a decrease in systemic vascular resistance…
View more